Injecta's fully isolated robotic technology disrupts the conventional approach to aseptic processing
Current market trends in aseptic fill-finish are now forcing pharmaceutical companies to adopt agile manufacturing strategies and embrace new technologies to meet the actual requirements for a highly variable production process. Central goal is to achieve flexible production in a safe, aseptic environment, implementing cost-saving solutions with a space-efficient design.
The pharmaceutical industry has been increasingly embracing injectables as a consistently profitable business sector. For decades, injection has been largely limited to in-patient use, with health professionals actively involved in administering doses intravenously, intramuscularly and subcutaneously. The introduction of prefilled syringes and injection devices has reduced the fear factor associated with outpatient injections.